These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7642685)

  • 1. Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.
    Schirrmacher V
    J Cancer Res Clin Oncol; 1995; 121(8):443-51. PubMed ID: 7642685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.
    Orentas RJ; Mackall CL
    Crit Rev Oncog; 2015; 20(3-4):315-27. PubMed ID: 26349422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic immunotherapy for cancer.
    Ribas A; Butterfield LH; Economou JS
    Oncologist; 2000; 5(2):87-98. PubMed ID: 10794799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research evolutions in immuno-oncology and their impact on the management of patients treated with immunotherapy].
    Caux C
    Bull Cancer; 2020 Jan; 107(1):6-9. PubMed ID: 31954504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-mediated immunotherapy of metastases: state of the art in 2005.
    Schirrmacher V
    Expert Opin Biol Ther; 2005 Aug; 5(8):1051-68. PubMed ID: 16050783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-Oncology in China.
    Lu S; Chabner BA
    Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of interventional oncology in the 21st century.
    Helmberger T
    Br J Radiol; 2020 Sep; 93(1113):20200112. PubMed ID: 32706978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
    Blair AB; Murphy A
    Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and challenges in immuno-oncology trials.
    Kiernan B
    Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncology, what's new in 2018].
    Latifyan S; Kakourou A; Ozdemir B; Zaman K; Vernadou A; Berthold D; Abdelhamid K; Bouchaab H; Peters S; Montemurro M; Aedo V; Michielin O; Zimmermann S; Stravodimou A
    Rev Med Suisse; 2019 Jan; 15(N° 632-633):78-81. PubMed ID: 30629376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New immunotherapeutic approaches in oncology and hematology].
    Kroemer M; Turco C; Galaine J; Deschamps M; Limat S; Borg C
    Transfus Clin Biol; 2015 Aug; 22(3):132-40. PubMed ID: 26068883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and future prospects of peptide-based cancer vaccines.
    Wada S; Yada E; Ohtake J; Fujimoto Y; Uchiyama H; Yoshida S; Sasada T
    Immunotherapy; 2016 Nov; 8(11):1321-1333. PubMed ID: 27993087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of malignant melanoma. New prospects].
    Hebbar M; Vanlemmens L; Lecomte S; Bonneterre J
    Rev Med Interne; 1995; 16(4):260-70. PubMed ID: 7746965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awaiting a new era of cancer immunotherapy.
    Hong CW; Zeng Q
    Cancer Res; 2012 Aug; 72(15):3715-9. PubMed ID: 22815525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The revolution of immuno-oncology therapy: specificities for the physicians].
    Dubois M; Ardin C; André F; Scherpereel A; Mortier L
    Med Sci (Paris); 2019 Dec; 35(12):946-948. PubMed ID: 31903898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Customer pyramid framework for CAR T-cell therapies in immuno-oncology.
    Malik NN; Durdy MB
    Drug Discov Today; 2016 Oct; 21(10):1563-1565. PubMed ID: 27640934
    [No Abstract]   [Full Text] [Related]  

  • 19. From New directions in immuno-oncology.
    Romero D
    Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.